Contract value: around EUR 120 million
Plants will be used for heavy residue conversion at the Nizhnekamsk refinery site
Munich, 11 February 2014 – Technology company The Linde Group has recently signed an engineering and procurement contract for two hydrogen plants in Nizhnekamsk, Republic of Tatarstan, Russian Federation. The contract was awarded by PSC TAIF-NK, a leader in the oil refining industry in Tatarstan. The contract is worth around EUR 120 million.
“We are delighted to have the opportunity to cooperate with PSC TAIF-NK and bring in our in-depth expertise in hydrogen technology,” said Professor Dr Aldo Belloni, Member of the Executive Board of Linde AG. “We are confident that this agreement will lead to further key contracts for our gases and engineering business in this important Eastern European growth market.”
Linde will be responsible for basic and detail engineering, procurement and supply of equipment and materials.
The two new hydrogen plants, each with a capacity of around 110,000 normal cubic metres per hour (Nm3/h), will supply high purity hydrogen to the heavy residue conversion complex at the Nizhnekamsk refinery site. The new hydrogen plants are planned to be delivered by the end of 2015.
PSC TAIF-NK operates the largest refinery in Tatarstan, including a gasoline plant and gas condensate processing plant.
About The Linde Group
The Linde Group is a world leading gases and engineering company with around 63,000 employees in more than 100 countries worldwide. In the 2012 financial year, Linde generated revenue of EUR 15.280 bn. The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development.
For more information, see The Linde Group online at www.linde.com
Dr Thomas Hagn